(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
3 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 1.47%
0.00% $ 0.430
Live Chart Being Loaded With Signals
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 10 000.00 |
Średni wolumen | 12 309.00 |
Kapitalizacja rynkowa | 8.60M |
EPS | $0 ( 2024-03-13 ) |
Następna data zysków | ( $0 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.30 |
ATR14 | $0 (0.00%) |
Crescita Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
FM.TO | 0.895 |
SKE.TO | 0.869 |
HOT-UN.TO | 0.859 |
CJR-B.TO | 0.855 |
GOOS.TO | 0.854 |
USA.TO | 0.849 |
TNT-UN.TO | 0.846 |
CRWN.TO | 0.844 |
ERO.TO | 0.837 |
JOY.TO | 0.831 |
10 Najbardziej negatywne korelacje | |
---|---|
HAC.TO | -0.879 |
SFC.TO | -0.869 |
E.TO | -0.858 |
THNC.TO | -0.844 |
CIA.TO | -0.827 |
SBB.TO | -0.825 |
EMP-A.TO | -0.824 |
SJ.TO | -0.814 |
RQN.TO | -0.813 |
ATE.TO | -0.809 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Crescita Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $17.52M |
Zysk brutto: | $8.86M (50.55 %) |
EPS: | $-0.0980 |
FY | 2023 |
Przychody: | $17.52M |
Zysk brutto: | $8.86M (50.55 %) |
EPS: | $-0.0980 |
FY | 2022 |
Przychody: | $23.53M |
Zysk brutto: | $13.18M (56.03 %) |
EPS: | $0.0417 |
FY | 2021 |
Przychody: | $16.77M |
Zysk brutto: | $10.01M (59.72 %) |
EPS: | $-0.0500 |
Financial Reports:
No articles found.
Crescita Therapeutics Inc
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including MMPE and DuraPeel for the development of topicals containing cannabis and hemp. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products in pre-clinical formulation utilizing MMPE technology for prescription treatments of skin diseases. Its non-prescription skincare products comprise skincare products, such as facial creams, cleansers, exfoliants, masks, serums, and suncare products for aging, acne, rosacea, pigmentation, dehydration, and sensitivity under the Laboratoire Dr Renaud brand; a line of dermocosmetic products for anti-aging medical procedures under the Pro-Derm brand; a line of products to target and treat various skincare concerns under the Alyria brand; and skincare products primarily for the Asian consumers under Dermazulene brand, as well as NCTF 135 HA, a skin revitalization solution primarily used for the improvement of skin quality and fine lines. The company has a development and licensing agreement with Sundial Growers Inc. to develop cannabis; a commercialization license agreement with Cantabria Labs Inc.; and a development and commercialization license agreement with Taro Pharmaceuticals Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej